Researchers at Karolinska Institutet in Sweden have linked resistance to treatment for a deadly form of kidney cancer to low mitochondrial content in the cell. When the researchers increased the mitochondrial content with an inhibitor, the cancer cells responded to the treatment. Their findings, which are published in Nature Metabolism, offer hope for more targeted cancer drugs.
New approach to treatment of deadly kidney cancer
June 28, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022